This is a statewide California ballot initiative, not a city or county measure.
It would allow the State of California to borrow money (issue bonds) to fund immunology and immunotherapy research — research focused on how the body’s immune system can fight disease.
Authorizes $8.4 billion in state general obligation bonds
Money would fund immunology and immunotherapy research
Research focuses on:
Cancer
Heart disease
Alzheimer’s disease
Other serious illnesses linked to the immune system
Bonds would be repaid over time from the state’s General Fund
Real-life example:
This works like a long-term mortgage. The state gets money now to fund research, and taxpayers repay it gradually over many years.
The funding is split evenly between two types of recipients:
A nonprofit medical research institute
Affiliated with the University of California
Selected by the California Department of Public Health
Must meet specific eligibility rules
Competitive grants for:
Public universities
Research institutions
Focus on immunology and immune-based treatments
The initiative includes price protections:
Any drugs or technologies developed using this funding must be:
Sold in California at least 20% below the national average price
Why this matters:
If taxpayers help fund discoveries, Californians are guaranteed lower prices if those discoveries turn into treatments.
According to the state’s fiscal estimate:
Bond repayment would cost about $500 million per year
Payments would last for about 25 years
Total cost depends on interest rates
If research leads to profitable discoveries:
The state could recover some costs
But this is not guaranteed
Paid from the California General Fund
That’s the same pool used for:
Schools
Healthcare
Public safety
Other state services
No new tax is specified, but bond repayment competes with other state spending.
Sponsor: Californians for Immunology Research and Cures
Major funder: Michelson Center for Public Policy
Petition circulation paid for by: Supporters of the measure
Yes.
It would apply across all of California.
No new tax is created, but the state takes on long-term debt.
No.
Research may or may not lead to new treatments or cures.
Yes, if successful:
Lower-priced drugs in California
Potential health advances
Possible long-term revenue if discoveries pay off
Appears as a statewide proposition
Voted on by all California voters
Title references bonds for immunology research
California Secretary of State – Initiative Status
https://www.sos.ca.gov/elections/ballot-measures/initiative-and-referendum-status
Attorney General Title & Summary (25-0026A1)
https://oag.ca.gov/initiatives
Borrows $8.4 billion to fund immune-system medical research
Costs about $500 million per year for decades
Includes price protections for Californians
Statewide measure requiring voter approval